Cargando…
The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family
Multiple system tauopathy with presenile dementia (MSTD) is an inherited disease caused by a (g) to (a) transition at position +3 in intron 10 of Tau. It belongs to the spectrum of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in Tau (FTDP-17T). Here we present the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702832/ https://www.ncbi.nlm.nih.gov/pubmed/18065436 http://dx.doi.org/10.1093/brain/awm280 |
_version_ | 1782168800937902080 |
---|---|
author | Spina, Salvatore Farlow, Martin R. Unverzagt, Frederick W. Kareken, David A. Murrell, Jill R. Fraser, Graham Epperson, Francine Crowther, R. Anthony Spillantini, Maria G. Goedert, Michel Ghetti, Bernardino |
author_facet | Spina, Salvatore Farlow, Martin R. Unverzagt, Frederick W. Kareken, David A. Murrell, Jill R. Fraser, Graham Epperson, Francine Crowther, R. Anthony Spillantini, Maria G. Goedert, Michel Ghetti, Bernardino |
author_sort | Spina, Salvatore |
collection | PubMed |
description | Multiple system tauopathy with presenile dementia (MSTD) is an inherited disease caused by a (g) to (a) transition at position +3 in intron 10 of Tau. It belongs to the spectrum of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in Tau (FTDP-17T). Here we present the longitudinal clinical, neuropsychological, neuroimaging, neuropathological, biochemical and genetic characterization of the MSTD family. Presenting signs were consistent with the behavioural variant of frontotemporal dementia in 17 of 21 patients. Two individuals presented with an atypical form of progressive supranuclear palsy and two others with either severe postural imbalance or an isolated short-term memory deficit. Memory impairment was present at the onset in 15 patients, with word finding difficulties and stereotyped speech also being common. Parkinsonism was first noted 3 years after the onset of symptoms. Neuroimaging showed the most extensive grey matter loss in the hippocampus, parahippocampal gyrus and frontal operculum/insular cortex of the right hemisphere and, to a lesser extent, in the anterior cingulate gyrus, head of the caudate nucleus and the posterolateral orbitofrontal cortex and insular cortex bilaterally. Neuropathologically, progressive nerve cell loss, gliosis and coexistent neuronal and/or glial deposits consisting mostly of 4-repeat tau were present in frontal, cingulate, temporal and insular cortices, white matter, hippocampus, parahippocampus, basal ganglia, selected brainstem nuclei and spinal cord. Tau haplotyping indicated that specific haplotypes of the wild-type allele may act as modifiers of disease presentation. Quantitative neuroimaging has been used to analyse the progression of atrophy in affected individuals and for predicting disease onset in an asymptomatic mutation carrier. This multidisciplinary study provides a comprehensive description of the natural history of disease in one of the largest known families with FTDP-17T. |
format | Text |
id | pubmed-2702832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27028322009-06-30 The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family Spina, Salvatore Farlow, Martin R. Unverzagt, Frederick W. Kareken, David A. Murrell, Jill R. Fraser, Graham Epperson, Francine Crowther, R. Anthony Spillantini, Maria G. Goedert, Michel Ghetti, Bernardino Brain Original Articles Multiple system tauopathy with presenile dementia (MSTD) is an inherited disease caused by a (g) to (a) transition at position +3 in intron 10 of Tau. It belongs to the spectrum of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in Tau (FTDP-17T). Here we present the longitudinal clinical, neuropsychological, neuroimaging, neuropathological, biochemical and genetic characterization of the MSTD family. Presenting signs were consistent with the behavioural variant of frontotemporal dementia in 17 of 21 patients. Two individuals presented with an atypical form of progressive supranuclear palsy and two others with either severe postural imbalance or an isolated short-term memory deficit. Memory impairment was present at the onset in 15 patients, with word finding difficulties and stereotyped speech also being common. Parkinsonism was first noted 3 years after the onset of symptoms. Neuroimaging showed the most extensive grey matter loss in the hippocampus, parahippocampal gyrus and frontal operculum/insular cortex of the right hemisphere and, to a lesser extent, in the anterior cingulate gyrus, head of the caudate nucleus and the posterolateral orbitofrontal cortex and insular cortex bilaterally. Neuropathologically, progressive nerve cell loss, gliosis and coexistent neuronal and/or glial deposits consisting mostly of 4-repeat tau were present in frontal, cingulate, temporal and insular cortices, white matter, hippocampus, parahippocampus, basal ganglia, selected brainstem nuclei and spinal cord. Tau haplotyping indicated that specific haplotypes of the wild-type allele may act as modifiers of disease presentation. Quantitative neuroimaging has been used to analyse the progression of atrophy in affected individuals and for predicting disease onset in an asymptomatic mutation carrier. This multidisciplinary study provides a comprehensive description of the natural history of disease in one of the largest known families with FTDP-17T. Oxford University Press 2008-01 2007-12-07 /pmc/articles/PMC2702832/ /pubmed/18065436 http://dx.doi.org/10.1093/brain/awm280 Text en © 2007 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Spina, Salvatore Farlow, Martin R. Unverzagt, Frederick W. Kareken, David A. Murrell, Jill R. Fraser, Graham Epperson, Francine Crowther, R. Anthony Spillantini, Maria G. Goedert, Michel Ghetti, Bernardino The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family |
title | The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family |
title_full | The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family |
title_fullStr | The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family |
title_full_unstemmed | The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family |
title_short | The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family |
title_sort | tauopathy associated with mutation +3 in intron 10 of tau: characterization of the mstd family |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702832/ https://www.ncbi.nlm.nih.gov/pubmed/18065436 http://dx.doi.org/10.1093/brain/awm280 |
work_keys_str_mv | AT spinasalvatore thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT farlowmartinr thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT unverzagtfrederickw thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT karekendavida thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT murrelljillr thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT frasergraham thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT eppersonfrancine thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT crowtherranthony thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT spillantinimariag thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT goedertmichel thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT ghettibernardino thetauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT spinasalvatore tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT farlowmartinr tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT unverzagtfrederickw tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT karekendavida tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT murrelljillr tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT frasergraham tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT eppersonfrancine tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT crowtherranthony tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT spillantinimariag tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT goedertmichel tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily AT ghettibernardino tauopathyassociatedwithmutation3inintron10oftaucharacterizationofthemstdfamily |